RQS
PDLI

Ramsey Quantitative Systems’s PDL BioPharma, Inc. PDLI Stock Holding History

Ramsey Quantitative Systems’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-135,643
Closed -$480K – 170
2015
Q4 		$480K Buy
135,643
+14,997
+12% +$62.8K 0.51% 143
2015
Q3 		$607K Buy
+120,646
New +$691K 0.72% 27

Other funds holding PDLI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ramsey Quantitative Systems's PDLI Position: Q1 2016 in Review

Ramsey Quantitative Systems sold out of PDL BioPharma, Inc. (PDLI) in Q1 2016, closing a stake of 135,643 shares — an estimated $480K sold.

Ramsey Quantitative Systems first reported a position in PDLI in Q3 2015 and held it in 2 quarters. The position peaked at $607K in Q3 2015. 195 funds tracked by Wall St. Rank hold PDLI as of Q1 2016.

  • Ramsey Quantitative Systems reported no remaining PDL BioPharma, Inc. position as of Q1 2016 after selling out during the quarter.
  • Ramsey Quantitative Systems sold 135,643 PDL BioPharma, Inc. shares in Q1 2016, an estimated $480K.
  • Ramsey Quantitative Systems first reported a position in PDL BioPharma, Inc. in Q3 2015 and held it in 2 quarters.
  • Ramsey Quantitative Systems's PDL BioPharma, Inc. position peaked at $607K in Q3 2015.
  • 195 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2016.

Based on Ramsey Quantitative Systems's 13F filing for Q1 2016, filed 2 May 2016.